BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival

BACKGROUND: Around 50% of primary melanomas harbour BRAF mutations, but their prognostic impact has not been clear. Recently, a BRAF-V600E mutation-specific antibody has become available for immunohistochemistry. Here, we investigated for the first time the prognostic impact of BRAF-V600E protein ex...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Cancer
Egile Nagusiak: Hugdahl, Emilia, Kalvenes, May Britt, Puntervoll, Hanne E, Ladstein, Rita G, Akslen, Lars A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2016
Gaiak:
Molecular Diagnostics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984864/
https://ncbi.nlm.nih.gov/pubmed/26924424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.44
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak